| Pretreatment Hematocrit Is Superior to Hemoglobin as a Prognostic Factor for Triple Negative Breast Cancer | |
| Chen, Bo; Dai, Danian; Tang, Hailin; Ai, Xiaohong; Chen, Xi; Zhang, Xiaoyan; Li, Zhiyan; Xie, Xiaoming* | |
| 刊名 | PLOS ONE
 |
| 2016 | |
| 卷号 | 11期号:11页码:e0165133 |
| 关键词 | Breast cancer,Anemia,Prognosis,Cancer treatment,Hematocrit,Multivariate analysis,Surgical and invasive medical procedures,Hemoglobin |
| ISSN号 | 1932-6203 |
| DOI | 10.1371/journal.pone.0165133 |
| URL标识 | 查看原文 |
| WOS记录号 | WOS:000387909300011 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/5677713 |
| 专题 | 南华大学 |
| 作者单位 | 1.[Dai, Danian 2.Tang, Hailin 3.Xie, Xiaoming 4.Chen, Bo] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Dept Breast Oncol,Canc Ctr, Guangzhou, Guangdong, Peoples R China. |
| 推荐引用方式 GB/T 7714 | Chen, Bo,Dai, Danian,Tang, Hailin,et al. Pretreatment Hematocrit Is Superior to Hemoglobin as a Prognostic Factor for Triple Negative Breast Cancer[J]. PLOS ONE,2016,11(11):e0165133. |
| APA | Chen, Bo.,Dai, Danian.,Tang, Hailin.,Ai, Xiaohong.,Chen, Xi.,...&Xie, Xiaoming*.(2016).Pretreatment Hematocrit Is Superior to Hemoglobin as a Prognostic Factor for Triple Negative Breast Cancer.PLOS ONE,11(11),e0165133. |
| MLA | Chen, Bo,et al."Pretreatment Hematocrit Is Superior to Hemoglobin as a Prognostic Factor for Triple Negative Breast Cancer".PLOS ONE 11.11(2016):e0165133. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论